Literature DB >> 19690867

Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia.

Martella Oreste1, Paradiso Galatioto Giuseppe, Pace Gianna, Angelucci Adriano, Necozione Stefano, Bologna Mauro, Vicentini Carlo.   

Abstract

PURPOSE: We verified if the measure of transition zone epithelial volume (TZepiV) could be a valid predictor of serum PSA value in men with benign prostatic hyperplasia (BPH).
MATERIALS AND METHODS: Between January 2005 and July 2008, a total of 90 patients undergoing transvesical suprapubic adenomectomy for sintomatic BPH were enrolled. In case of an elevated PSA level (above 4 ng/ml) or abnormal digital rectal examination, systematic multisite biopsies were performed preoperatively to rule out prostate cancer. We have examined PSA levels before and after open surgery, TZ weight as measured by the pathologist and TZepiV by multiplying percentage of epithelium of a single biopsy core with the weight of adenoma. Means, Spearman correlation coefficients and percent change were calculated for all variables and intervals.
RESULTS: The mean serum PSA decreased from 4.8 ng/ml preoperatively to 0.5 ng/ml postoperatively. The mean decrease in PSA was 90% (range 70-99%).The mean weight of enucleated adenoma was 67 gr.(range 18-201) and the TZepiV was 7.7 ml (0.3-28.4). Overall, both TZ volume and TZepiV were correlated to PSA value with TZepiV representing the most predictive variable for PSA (r = 0.54 P = 0.002 vs. r = 0.26 P = 0.02). When we analyzed different ranges of PSA values, only TZepiV was always significantly proportional to PSA.
CONCLUSIONS: Ninety percentage of serum PSA level comes from TZ in range of 0.01-0.17 ng/ml/gr. In presence of equal BPH volumes, the amount of epithelium can be different and it is the main determinant in PSA increase. Thus, TZ epithelial volume could represent a new useful clinical tool able to increase the specificity of PSA in the diagnosis of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690867     DOI: 10.1007/s00345-009-0465-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard.

Authors:  H C Graves; N Wehner; T A Stamey
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

2.  Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate.

Authors:  J Kalish; W H Cooner; S D Graham
Journal:  Urology       Date:  1994-05       Impact factor: 2.649

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy.

Authors:  Takashi Ohigashi; Kent Kanao; Eiji Kikuchi; Ken Nakagawa; Jun Nakashima; Ken Marumo; Masaru Murai
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

5.  Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.

Authors:  A R Zlotta; B Djavan; M Marberger; C C Schulman
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

6.  Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma.

Authors:  M Bazinet; A W Meshref; C Trudel; S Aronson; F Péloquin; M Nachabe; L R Bégin; M M Elhilali
Journal:  Urology       Date:  1994-01       Impact factor: 2.649

7.  The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age.

Authors:  R J Babaian; H Miyashita; R B Evans; E I Ramirez
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

8.  Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

Authors:  M C Benson; I S Whang; A Pantuck; K Ring; S A Kaplan; C A Olsson; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Predicted and actual change in serum PSA following prostatectomy for BPH.

Authors:  S N Lloyd; G N Collins; G B McKelvie; M Hehir; A C Rogers
Journal:  Urology       Date:  1994-04       Impact factor: 2.649

10.  Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.

Authors:  L S Marks; B Treiger; F J Dorey; Y S Fu; J B deKernion
Journal:  Urology       Date:  1994-10       Impact factor: 2.649

View more
  2 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.